References

Autonomic nervous system function in Huntington’s disease

10.1136/jnnp.72.6.726 · 2002 · External reference

Advances in Huntington’s disease biomarkers: a 10-year bibliometric analysis and a comprehensive review

10.3390/biology14020129 · 2025 · External reference

Brugada syndrome in spinal and bulbar muscular atrophy

2014 · External reference

Spectral analysis of heart rate variability in patients with Machado-Joseph disease

10.1016/j.autneu.2009.11.008 · 2010 · External reference

Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington’s disease: clinical consequences and therapeutic implications

2007 · External reference

Molecular genetics of hereditary ataxias

1994 · External reference

Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype

10.1212/wnl.51.4.1081 · 1998 · External reference

Blood-to-brain communication in aging and rejuvenation

10.1038/s41593-022-01238-8 · 2023 · External reference

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease

10.1084/jem.20080178 · 2008 · External reference

Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients

2017 · External reference

High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington’s disease expansion mutation carriers shows normal mitochondrial respiratory function

10.1371/journal.pone.0175248 · 2017 · External reference

Brain-periphery interactions in Huntington’s disease: mediators and lifestyle interventions

10.3390/ijms25094696 · 2024 · External reference

Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington’s disease

10.1007/s00415-008-0964-x · 2008 · External reference

Ophthalmic features of spinocerebellar ataxia type 7

10.1038/eye.2017.135 · 2018 · External reference

Evidence of cardiac electrical remodeling in patients with Huntington disease

10.1002/brb3.1077 · 2018 · External reference

Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model

10.1016/j.bbi.2014.09.011 · 2015 · External reference

DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder

10.1007/s00415-020-10218-6 · 2021 · External reference

Metabolic disturbances in plasma as biomarkers for Huntington’s disease

10.1016/j.jnutbio.2015.12.001 · 2016 · External reference

A pilot study: handgrip as a predictor in the disease progression of SCA3

10.1186/s13023-023-02948-3 · 2023 · External reference

Stage-specific serum proteomic signatures reveal early biomarkers and molecular pathways in Huntington’s disease progression

10.3390/cells14151195 · 2025 · External reference

Systemic manifestation and contribution of peripheral tissues to Huntington’s disease pathogenesis

10.1016/j.arr.2021.101358 · 2021 · External reference

Muscle-to-CNS signaling in physiological homeostasis, aging, and disease

10.1016/j.molmed.2026.03.006 · 2026 · External reference

Increased apoptosis, huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington’s disease subjects

10.1038/sj.cdd.4401967 · 2006 · External reference

Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington’s disease

10.1002/mds.23258 · 2011 · External reference

Body composition and bone mineral density in Huntington’s disease

10.1016/j.nut.2018.08.005 · 2019 · External reference

An established case of dentatorubral pallidoluysian atrophy (DRPLA) with unusual features on muscle biopsy

10.1053/ejpn.2000.0279 · 2000 · External reference

Neuro-cardio mechanisms in Huntington’s disease and other neurodegenerative disorders

10.3389/fphys.2018.00559 · 2018 · External reference

Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

10.1038/ng0997-65 · 1997 · External reference

A comprehensive endocrine description of Kennedy’s disease revealing androgen insensitivity linked to CAG repeat length

2002 · External reference

A comprehensive endocrine description of Kennedy’s disease revealing androgen insensitivity linked to CAG repeat length

2002 · External reference

Autonomic nervous function in Huntington’s disease

10.1001/archneur.1988.00520270087025 · 1988 · External reference

Infantile spinocerebellar ataxia type 7: case report and a review of the literature

10.1016/j.jns.2015.04.040 · 2015 · External reference

Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington’s disease

10.1172/jci.insight.140614 · 2020 · External reference

Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6

10.1016/j.cell.2013.05.059 · 2013 · External reference

Interleukin-6 as a marker of Huntington’s disease progression: systematic review and meta-analysis

2023 · External reference

Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of Italian patients with spinal-bulbar muscular atrophy

2018 · External reference

Metabolic alterations in spinal and bulbar muscular atrophy

10.1016/j.neurol.2020.03.020 · 2020 · External reference

Skeletal muscle characteristics and mitochondrial function in Huntington’s disease patients

10.1002/mds.27031 · 2017 · External reference

Clinical features of Huntington’s disease

10.1007/978-3-319-71779-1_1 · 2018 · External reference

Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington’s disease knock-in mice

10.1093/hmg/ddg046 · 2003 · External reference

Fibroblasts in Huntington’s disease

10.1056/nejm197512112932403 · 1975 · External reference

Skin fibroblasts in Huntington disease

1981 · External reference

Body composition analysis in premanifest Huntington’s disease reveals lower bone density compared with controls

10.1371/currents.rrn1214 · 2011 · External reference

The molecular basis of spinocerebellar ataxia type 7

10.3389/fnins.2022.818757 · 2022 · External reference

Lethal form of spinocerebellar ataxia type 7 with early onset in childhood

10.1016/j.arcped.2017.09.029 · 2018 · External reference

Non-alcoholic fatty liver disease in spinal and bulbar muscular atrophy

10.1212/wnl.0000000000004748 · 2017 · External reference

Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington’s disease: a proton magnetic resonance spectroscopy study

10.1136/jnnp.62.1.27 · 1997 · External reference

Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes

10.1093/hmg/ddh139 · 2004 · External reference

Progressive hepatic mitochondrial dysfunction in premanifest Huntington’s disease

10.1002/mds.25862 · 2014 · External reference

A patient-derived cellular model for Huntington’s disease reveals phenotypes at clinically relevant CAG lengths

10.1091/mbc.e18-09-0590 · 2018 · External reference

Cardiac autonomic involvement in Huntington’s disease

10.1007/s10072-024-07428-5 · 2024 · External reference

Evidence for impairment of energy metabolism in vivo in Huntington’s disease using localized 1H NMR spectroscopy

10.1212/wnl.43.12.2689 · 1993 · External reference

A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases

10.3389/fnmol.2022.974167 · 2022 · External reference

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

10.1038/ng1194-221 · 1994 · External reference

Bone fragility and fracture characteristics in patients with spinal and bulbar muscular atrophy

10.1111/ene.70457 · 2025 · External reference

Biomarkers in spinocerebellar ataxias

10.1007/s12311-025-01856-5 · 2025 · External reference

Heart rate variability in Huntington disease: a long-term longitudinal study

10.1159/000525415 · 2022 · External reference

Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA)

10.1038/ng0194-9 · 1994 · External reference

Myopathy as a first symptom of Huntington’s disease in a Marathon runner

10.1002/mds.21550 · 2007 · External reference

Spinocerebellar Ataxia Type 7

2026 · External reference

Polyglutamines placed into context

10.1016/s0896-6273(03)00328-3 · 2003 · External reference

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

10.1038/352077a0 · 1991 · External reference

Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion

10.1001/archneur.65.4.476 · 2008 · External reference

Impaired insulin sensitivity and secretion in normoglycemic patients with spinocerebellar ataxia type 1

10.1002/mds.23176 · 2010 · External reference

Peripheral and autonomic nervous system involvement in spinocerebellar ataxia type 3: unveiling an invisible burden

10.1007/s00415-025-13588-x · 2026 · External reference

Static and dynamic ocular motor abnormalities as potential biomarkers in spinocerebellar Ataxia type 3

10.1007/s12311-020-01217-4 · 2021 · External reference

Autophagic vacuolar myopathy involving the phenotype of spinocerebellar ataxia type 3

10.1111/neup.12860 · 2023 · External reference

Polyglutamine repeats in neurodegenerative diseases

10.1146/annurev-pathmechdis-012418-012857 · 2019 · External reference

Abnormal in vivo skeletal muscle energy metabolism in Huntington’s disease and dentatorubropallidoluysian atrophy

10.1002/1531-8249(200007)48:1<72::aid-ana11>3.0.co;2-i · 2000 · External reference

Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy

10.1212/wnl.0000000000007097 · 2019 · External reference

Heart rate variability during wake and sleep in Huntington’s disease patients: an observational, cross-sectional, cohort study

10.1159/000520754 · 2021 · External reference

Dysfunction of the CNS-heart axis in mouse models of Huntington’s disease

10.1371/journal.pgen.1004550 · 2014 · External reference

Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease

10.1016/j.nbd.2006.09.016 · 2007 · External reference

Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression

10.1371/journal.pone.0000647 · 2007 · External reference

Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington’s disease

10.1038/ejhg.2010.72 · 2010 · External reference

Effect of Triheptanoin on caudate atrophy and motor scores in patients with early-stage Huntington disease: a phase II study

10.1212/wnl.0000000000210194 · 2025 · External reference

Heart rate variability in type 2 spinocerebellar ataxia

2010 · External reference

Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2

10.1111/j.1600-0404.2011.01494.x · 2012 · External reference

Huntington’s disease and diabetes: chronological sequence of its association

10.3233/jhd-170253 · 2017 · External reference

Renal complications in two patients with dentatorubral-pallidoluysian atrophy

10.5414/cnp67044 · 2007 · External reference

Modulation of neurodegeneration by molecular chaperones

10.1038/nrn1587 · 2005 · External reference

Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs

10.1007/s00415-012-6787-9 · 2013 · External reference

Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy

10.1212/wnl.32.8.798 · 1982 · External reference

Insulin resistance and motor function in spinal and bulbar muscular atrophy

2017 · External reference

A metabolic study of Huntington’s disease

10.1371/journal.pone.0146480 · 2016 · External reference

Huntington’s disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations

10.1093/brain/awae007 · 2024 · External reference

Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity

10.1074/jbc.m211224200 · 2003 · External reference

Cutaneous accumulation of abnormal polyglutamine proteins of patients with dentatorubral-pallidoluysian atrophy

10.1111/j.1468-1331.2009.02658.x · 2009 · External reference

Polyglutamine spinocerebellar ataxias - from genes to potential treatments

10.1038/nrn.2017.92 · 2017 · External reference

Hypothalamic-endocrine aspects in Huntington’s disease

10.1111/j.1460-9568.2006.04985.x · 2006 · External reference

Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration

10.1038/s41583-019-0255-9 · 2020 · External reference

Microglial activation in regions related to cognitive function predicts disease onset in Huntington’s disease: a multimodal imaging study

2011 · External reference

Spinocerebellar ataxias type 1, 2 and 3: a study of heart rate variability

10.1111/j.1600-0404.2007.00945.x · 2008 · External reference

Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients

10.1136/jnnp-2015-311305 · 2016 · External reference

Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review

10.3389/fneur.2018.00844 · 2018 · External reference

Optic disc and retinal architecture changes in patients with spinocerebellar ataxia type 2

10.1002/mds.29675 · 2024 · External reference

Inclusion body myositis in patients with spinocerebellar ataxia types 3 and 6

10.1136/jnnp-2020-323270 · 2020 · External reference

Heterogeneous phenotype and cardiovascular comorbidities in Swedish patients with spinobulbar muscular atrophy

10.1007/s00415-025-13605-z · 2026 · External reference

The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy

10.1007/s00415-018-8790-2 · 2018 · External reference

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

10.1002/mds.20373 · 2005 · External reference

Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6)

10.1007/s004010050787 · 1998 · External reference

Cardiac dysfunction in the BACHD mouse model of Huntington’s disease

10.1371/journal.pone.0147269 · 2016 · External reference

HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism

10.1093/hmg/ddi319 · 2005 · External reference

Sympathetic skin response and heart rate variability in patients with Huntington disease

10.1001/archneur.56.10.1248 · 1999 · External reference

Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington’s disease

10.1016/j.freeradbiomed.2012.06.008 · 2012 · External reference

A critical evaluation of inflammatory markers in Huntington’s disease plasma

10.3233/jhd-130049 · 2013 · External reference

Specific biomarkers in spinocerebellar ataxia type 3: a systematic review of their potential uses in disease staging and treatment assessment

10.3390/ijms25158074 · 2024 · External reference

J wave syndromes in patients with spinal and bulbar muscular atrophy

10.1007/s00415-022-10992-5 · 2022 · External reference

Electrocardiogram abnormalities suggest aberrant cardiac conduction in Huntington’s disease

10.1002/mdc3.12596 · 2018 · External reference

The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2

1995 · External reference

Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease

10.1212/wnl.0b013e318282514e · 2013 · External reference

Depressed baroreflex sensitivity from spontaneous oscillations of heart rate and blood pressure in SCA1 and SCA2

10.1111/ane.13151 · 2019 · External reference

Heart rate variability and falls in Huntington’s disease

10.1007/s10286-020-00669-2 · 2021 · External reference

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes

10.1016/0092-8674(93)90585-e · 1993 · External reference

An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington’s disease related cardiomyopathy

10.1016/j.bbadis.2016.08.019 · 2016 · External reference

Polyglutamine disorders including Huntington’s disease

2007 · External reference

Purine nucleotides metabolism and signaling in Huntington’s disease: search for a target for novel therapies

10.3390/ijms22126545 · 2021 · External reference

Spinocerebellar Ataxia Type 17

2005 · External reference

Massive CAG repeat expansion and somatic instability in maternally transmitted infantile spinocerebellar ataxia type 7

10.1001/jamaneurol.2014.1902 · 2015 · External reference

Clinical correlates of mitochondrial function in Huntington’s disease muscle

10.1002/mds.21540 · 2007 · External reference

Exploring the brain-body composition relationship in Huntington’s disease

2020 · External reference

Inflammation in Huntington’s disease: a few new twists on an old tale

10.1016/j.jneuroim.2020.577380 · 2020 · External reference

Kennedy’s disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review

10.1016/j.endonu.2015.02.008 · 2015 · External reference

Beyond the brain: widespread pathology in Huntington’s disease

10.1016/s1474-4422(09)70178-4 · 2009 · External reference

Peripheral inflammation links with the severity of clinical phenotype in spinocerebellar Ataxia 2

10.1002/mds.29359 · 2023 · External reference

Massive SCA7 expansion detected in a 7-month-old male with hypotonia, cardiomegaly, and renal compromise

10.1111/j.1469-8749.2007.00140.x · 2007 · External reference

Abnormal peripheral chemokine profile in Huntington’s disease

2011 · External reference

Cutaneous changes in Huntington’s disease. Preliminary report

10.1111/j.1365-4362.1984.tb01244.x · 1984 · External reference

Peripheral inflammation in spinocerebellar ataxia type 3: associations with genetic and clinical manifestations

10.1007/s00011-025-02102-8 · 2025 · External reference

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel

10.1038/ng0197-62 · 1997 · External reference

Skeletal muscle pathology in Huntington’s disease

10.3389/fphys.2014.00380 · 2014 · External reference

Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia

10.1038/sj.ejhg.5200617 · 2001 · External reference